Profound Medical Corp. (PROF): Capital Expenditures
$176.0K
Year ended 2025-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $176.0K | n/a | 2026-03-05, From 2025-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Profound Medical Corp. (PROF) | 2025-12-31 | $176.0K | n/a |
| Allurion Technologies, Inc. (ALUR) | 2024-12-31 | $611.0K | -62.0% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $2.34M | +312.1% |
| Nephros Inc (NEPH) | 2024-12-31 | $55.0K | -26.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $192.0K | +140.0% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $142.0K | +2.9% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $42.3K | -98.5% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $68.0K | -84.7% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $1.33M | -85.6% |
Compare PROF, ALUR, VVOS, NEPH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗